Company Filing History:
Years Active: 2003
Title: Kenneth Lee Rosenthal: Innovator in HIV Research
Introduction
Kenneth Lee Rosenthal is a notable inventor based in Ancaster, Canada. He has made significant contributions to the field of HIV research, particularly in the expansion of T-cells from HIV-infected subjects. His innovative methods aim to improve treatment options for patients living with HIV.
Latest Patents
Kenneth Lee Rosenthal holds a patent for "Efficient ex vivo expansion of CD4+ and CD8- T-cells from HIV infected subjects." This patent discloses methods for the expansion of CD4, CD8, and double-positive T-cells from HIV-infected patients, allowing for the maintenance of low levels of HIV. The invention also includes methods for inhibiting HIV gene expression and provides a means for the rapid screening of cells derived from HIV-infected patients to assess the suitability of various antiviral treatments. Furthermore, it offers a way to generate cell banks for immune reconstitution and methods for treating or modifying expanded cell populations prior to infusion to enhance therapeutic effectiveness.
Career Highlights
Kenneth Lee Rosenthal is associated with Hemosol Inc., where he continues to work on innovative solutions in the field of immunology and HIV treatment. His research has the potential to significantly impact the lives of those affected by HIV.
Collaborations
He collaborates with David N Bell, who is also involved in similar research areas. Their combined efforts contribute to advancing the understanding and treatment of HIV.
Conclusion
Kenneth Lee Rosenthal's work exemplifies the importance of innovation in medical research, particularly in the fight against HIV. His contributions through patents and collaboration with other professionals highlight the ongoing efforts to improve patient outcomes in this critical area of health.